ℹ️ Compiled from public regulatory records · Last regulator revision: May 18, 2026🚩 Report this page

Salicylic Acid

Active ingredient · 2 therapeutic classes

Sold as Kingskin · Acne Dots · Compound W · Quick Action · Wart Removers

US FDAGB MHRACA Health Canada

Drug class: Other Antifungals For Topical Use
Availability: Prescription and OTC
Routes: Topical, Transdermal
Markets covered: 3
Products on record: 197
FDA reports (12 mo): 212

D01AEOther Antifungals For Topical Use S01BCAntiinflammatory Agents, Non-Steroids

Overview

Salicylic Acid is an active pharmaceutical ingredient in the Other Antifungals For Topical Use group (D01AE). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.

Regulatory status by market

Market	Regulator	Products	Last revision
US United States	FDA	162	May 18, 2026
GB United Kingdom	MHRA	31	April 24, 2026
CA Canada	Health Canada	4	March 22, 2025

USUnited States· FDA

162 products

Uses

USOfficial regulatory label· revised February 10, 2026[1]

Uses Anti-acne Tighten skin Moisturize Improve fine lines Whitening

How to take

USOfficial regulatory label

GBUnited Kingdom· MHRA

31 products

Uses

GBOfficial regulatory label· revised May 30, 2025[2]

For the treatment of corns, calluses, common warts and plantar warts (verrucas).

How to take

GBOfficial regulatory label

CACanada· Health Canada

4 products

4 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [3].

Brands in Canada (4)

Drug interactions

Known interactions involving Salicylic Acid. Select one for details. This list is informational and not a complete interaction checker.

Acetazolamide Brinzolamide Deferasirox Dorzolamide Ketorolac Leflunomide Methazolamide Methotrexate Ramucirumab Teriflunomide Abciximab Activated Charcoal Adapalene Alendronate Aliskiren Alitretinoin Alteplase Aluminum Hydroxide Amikacin Amlodipine Apixaban Argatroban Azilsartan Benazepril Betamethasone Betrixaban Bexarotene Bivalirudin Budesonide Calcium Carbonate Captopril Chlorpropamide Ciprofloxacin Citalopram Clomipramine Clopidogrel Cyclosporine Dalteparin Deflazacort Delafloxacin Desirudin Desvenlafaxine Dexamethasone Didanosine Digoxin Drospirenone Drotrecogin Alfa Duloxetine Edoxaban Enalapril Enoxaparin Eplerenone Epoprostenol Eprosartan Eptifibatide Escitalopram Felodipine Fenfluramine Fludrocortisone Fluoxetine Fluvoxamine Fondaparinux Fosinopril Gatifloxacin Gemifloxacin Gentamicin Glimepiride Glipizide Glyburide Heparin Hydralazine Hydrocortisone Ibandronate Iloprost Imipramine Insulin Degludec Insulin Detemir Insulin Glargine Insulin Lispro Irbesartan Isotretinoin Isradipine Kanamycin Lepirudin Levamlodipine Levofloxacin Lisinopril Losartan Macimorelin Magnesium Carbonate Magnesium Hydroxide Magnesium Oxide Methylprednisolone Milnacipran Moexipril Moxifloxacin Nateglinide Nicardipine Nifedipine Nimodipine Nisoldipine Norfloxacin Ofloxacin Olmesartan Pamidronate Paroxetine Pemetrexed Perindopril Picosulfurate Pitolisant Plazomicin Potassium Citrate Pralatrexate Prasugrel Prednisolone Prednisone Probenecid Quinapril Ramipril Repaglinide Reteplase Risedronic Acid Rivaroxaban Sertraline Sibutramine Sodium Acetate Sodium Bicarbonate Sodium Citrate Sodium Sulfate Streptomycin Tazarotene Telmisartan Tenecteplase Ticagrelor Tirofiban Tobramycin Tolazamide Tolbutamide Trandolapril Treprostinil Tretinoin Triamcinolone Trifarotene Tromethamine Trovafloxacin Valproate Valsartan Venlafaxine Verapamil Vilazodone Warfarin Zoledronic Acid Acebutolol Acetaminophen Atenolol Betaxolol Bisoprolol Bumetanide Carvedilol Dexlansoprazole Diltiazem Donepezil Esmolol Esomeprazole Ethacrynate Furosemide Hyaluronidase Labetalol Lansoprazole Lithium Carbonate Metoprolol Nadolol Nebivolol Niacin Omeprazole Pantoprazole Phenytoin Pindolol Propranolol Rabeprazole Sotalol Spironolactone Timolol Torsemide

Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.

Sources & citations

[1]FDA DailyMed · 010029a3-8c1a-4f… · revised February 10, 2026 [PDF]
[2]MHRA (UK) · PL560580003 · revised May 30, 2025
[3]Health Canada (DPD) · 00266493 · revised March 22, 2025
[4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.

Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.